sFlt-1 is expressed in several tumors, including breast cancer, colorectal cancer, and acute myeloid leukemia (AML), and the PIGF/sFlt-1 ratio, as well as sFlt-1, have been linked to the prognosis of a variety of malignancies (135). Here, PIGF is linked to acute myeloid leukemia.